'That is unheard of': AstraZeneca vaccine expected to be fourth consecutive to get FDA approval

The AstraZeneca vaccine, studied in Cincinnati, is reporting an efficacy rate of 79% as it prepares to become the fourth vaccine to ask the FDA for emergency approval.